Concurrently depleting regulatory T cells and activating cytotoxic T cells in tumours

IF 26.8 1区医学 Q1 ENGINEERING, BIOMEDICAL Nature Biomedical Engineering Pub Date : 2024-12-20 DOI:10.1038/s41551-024-01305-4

引用次数: 0

Abstract

An anti-4-1BB antibody fused to interleukin-15 via a peptide that is sensitive to tumour proteases concurrently depletes regulatory T cells and expands cytotoxic T cells in the tumour microenvironment. This fusion protein augments tumour inhibition without increasing systemic toxicity.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Nature Biomedical Engineering Medicine-Medicine (miscellaneous)

CiteScore

45.30

自引率

1.10%

发文量

138

期刊介绍： Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.

期刊最新文献

Advancing breast cancer risk stratification using multimodal AI FAS-less allogeneic CAR T cells Concurrently depleting regulatory T cells and activating cytotoxic T cells in tumours Acoustic-pressure-driven ultrasonic activation of the mechanosensitive receptor RET and of cell proliferation in colonic tissue The analgesic potential of heavy water